z-logo
open-access-imgOpen Access
Identification of Expression Patterns and Potential Prognostic Significance of m5C-Related Regulators in Head and Neck Squamous Cell Carcinoma
Author(s) -
Zhenyuan Han,
Biao Yang,
Yu Wang,
Xiuxia Zeng,
Zhen Tian
Publication year - 2021
Publication title -
frontiers in oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.834
H-Index - 83
ISSN - 2234-943X
DOI - 10.3389/fonc.2021.592107
Subject(s) - head and neck squamous cell carcinoma , epigenetics , cancer research , methylation , oncology , rna methylation , regulation of gene expression , biology , dna methylation , gene expression , dnmt1 , medicine , gene , bioinformatics , cancer , methyltransferase , head and neck cancer , genetics
5-Methylcytosine (m 5 C) methylation is a major epigenetic technique of RNA modification and is dynamically mediated by m 5 C “writers,” “erasers,” and “readers.” m 5 C RNA modification and its regulators are implicated in the onset and development of many tumors, but their roles in head and neck squamous cell carcinoma (HNSCC) have not yet been completely elucidated. In this study, we examined expression patterns of core m 5 C regulators in the publicly available HNSCC cohort via bioinformatic methods. The differentially expressed m 5 C regulators could divide the HNSCC cohort into four subgroups with distinct prognostic characteristics. Furthermore, a three-gene expression signature model, comprised of NSUN5, DNMT1, and DNMT3A, was established to identify individuals with a high or low risk of HNSCC. To explore the underlying mechanism in the prognosis of HNSCC, screening of differentially expressed genes, followed by the analysis of functional and pathway enrichment, from individuals with high- or low-risk HNSCC was performed. The results revealed a critical role for m 5 C RNA modification in two aspects of HNSCC: (1) dynamic m 5 C modification contributes to the regulation of HNSCC progression and (2) expression patterns of NSUN5, DNMT1, and DNMT3A help to predict the prognosis of HNSCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom